Advanced Medical Solutions (GB:AMS) has released an update.
Advanced Medical Solutions Group plc, a leader in tissue-healing medical devices, has announced its total issued share capital as of August 30, 2024, which consists of 217,679,768 ordinary shares with voting rights. This information is vital for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules. The company, with a global sales network and R&D innovation hubs worldwide, specializes in products ranging from tissue adhesives to wound care dressings marketed under multiple brands.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.
